• Molecular NameTretinoin
  • SynonymAll Trans Retinoic Acid; All Trans-Retinoic Acid; ATRA; beta-Retinoic Acid; Retionic Acid; tretinoin
  • Weight300.442
  • Drugbank_IDDB00755
  • ACS_NO302-79-4
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)5.85
  • pkaN/A
  • LogD (pH=7, predicted)3.26
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.31
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors1
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds5
  • TPSA37.3
  • StatusFDA approved
  • AdministrationTopical, oral
  • PharmacologyA drug commonly used to treat acne vulgaris and keratosis pilaris.
  • Absorption_valueN/A
  • Absorption (description)1-31% (topical)
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding95.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life0.5~2 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A